PubMed Health⌕ Search

Biomedical subjects

P H Stern

Publications and source records attributed to P H Stern.

At least 19 recordsLinked to original sources
PubMed1992

Effects of endothelin-1 on signal transduction in UMR-106 osteoblastic cells.

Endothelin-1 is now recognized to affect the functions of a number of tissues and to activate calcium/phospholipid second messenger pathways in target cells. In the present study, we characterized its effects on signal transduction in UMR-106 cells. To study calcium transients elicited by endothelin-1, cells were loaded either with fluo-3 (for the measurement of cytosolic free calcium) or chlortetracycline (for the measurement of intracellularly stored calcium) as fluorescent probes. Intracellular production of inositol phosphates and cyclic AMP was also measured. Endothelin-1 elicited dose-dependent cytosolic calcium transients with an ED50 of 20 nM. This effect was also seen in EGTA-containing or calcium-free medium; however, the signals were reduced in magnitude. The dihydropyridine calcium channel antagonist nifedipine did not affect the response. Repeated administration of endothelin-1 resulted in homologous desensitization of the response. A 4 minute pretreatment with phorbol ester reduced the initial response to endothelin-1 in both calcium-containing and calcium-free media. A 24 h pretreatment with indomethacin had no effect on response. Using chlortetracycline as an indicator, a significant reduction in intracellularly stored calcium by endothelin-1 was observed. This was prevented by 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate, a blocker of calcium release from internal stores. Endothelin-1 also stimulated the dose-dependent production of inositol phosphates by UMR-106 cells. Indomethacin was also without effect on this process. The increase in inositol trisphosphates was seen within the same time frame as the increase in cytosolic calcium. Endothelin-1 did not influence cyclic AMP production over 5 minutes in these cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Calcium↗
PubMed1992

Effects of cyclosporins and transforming growth factor beta 1 on thyroid hormone action in cultured fetal rat limb bones.

To study the mechanism of action of thyroid hormones on bone, we examined the effects of immunosuppressive and nonimmunosuppressive cyclosporins, as well as of transforming growth factor beta 1 (TGF beta 1), 17 beta-estradiol (E2), and dihydroxytestosterone (DHT) on thyroxine (T4)- and triiodothyronine (T3)-stimulated bone resorption in fetal rat limb bones. The immunosuppressive cyclosporins A (CsA) and G (CsG) inhibited thyroid hormone (T4 + T3)-stimulated resorption and beta-glucuronidase release into the culture medium, whereas the weak or nonimmunosuppressive cyclosporins D (CsD) and H (CsH) did not show this effect. Increasing the medium calcium concentration reduced the ability of T4 to stimulate 45Ca release, while not significantly affecting the response to CsA. TGF beta 1 elicited a biphasic effect when administered together with T4. During the first 3 days of culture, TGF beta 1 elicited a small, nonsignificant decrease in released 45Ca; during a subsequent 3 days of culture, it enhanced T4-stimulated bone resorption significantly. These effects differed from those of TGF beta 1 on parathormone-stimulated resorption. E2 and DHT did not influence the action of T4 on bone tissue. These results suggest that the mechanism of action of thyroid hormones on bone may involve immune factors, as well.

Animals↗
PubMed1992

Interactions of tumor necrosis factor with local and systemic factors in fetal rat limb bones.

In many tissues the actions of tumor necrosis factor-alpha (TNF) are indirectly mediated through the production of autacoids or other cytokines. To determine the role that these factors might have in the action of TNF on bone resorption, we examined the effects of several selective inhibitors on TNF-stimulated resorption. The cyclooxygenase inhibitor indomethacin did not prevent TNF-stimulated resorption in fetal rat limb bones. Stimulation of resorption by TNF was also unaffected by the platelet activating factor antagonist WEB 2086. A 17.5 kD interleukin receptor antagonist protein, at concentrations that completely blocked the bone-resorbing actions of maximally effective concentrations of interleukin (IL)-1 beta, failed to affect the stimulatory actions of TNF. TNF-stimulated resorption was inhibited by both interferon-gamma and dexamethasone. Dexamethasone inhibited TNF-stimulated resorption more effectively than it inhibited parathyroid hormone (PTH)-stimulated resorption. When bones were treated simultaneously with low concentrations of TNF and PTH, potentiation of the bone-resorbing effects was elicited. These results suggest that TNF stimulates resorption through a pathway different from that by which PTH produces its effects. Transforming growth factor-beta (TGF-beta) enhanced responses to TNF; TGF-beta failed to inhibit the effects of TNF, even in long-term culture or when bones were pretreated with TGF-beta. Synergistic interactions between TNF and several other bone-resorbing factors have now been demonstrated. In contrast to the actions of TNF on certain other functions, the bone-resorbing effects of TNF, as determined in the fetal rat limb bone system, do not seem to be mediated by PAF, IL-1, or prostaglandins.

Animals↗
PubMed1992

Effects of gallium nitrate on calcium transients in UMR-106 rat osteoblastic osteosarcoma cells.

Gallium nitrate is an effective antihypercalcemic and antiresorptive agent. Although its effects on osteoclasts are well documented, the mechanism of action of gallium nitrate on osteoblasts is still not established. To determine the effects of gallium nitrate on calcium signalling, we studied its effects on intracellular calcium concentration in UMR-106 rat osteoblastic osteosarcoma cell line. Cells were loaded with a calcium binding fluorescent dye, fluo-3. Changes in fluorescence reflected changes in cytosolic calcium. Gallium nitrate elicited a dose-dependent biphasic calcium transient with an initial decrease followed by an increase, and these changes were seen at high extracellular calcium concentration. Markedly altered signal was seen in nominal calcium-free medium, suggesting that gallium nitrate mobilized calcium only partly from intracellular stores. Gallium nitrate, at concentrations as low as 3 micrograms/ml, inhibited parathyroid hormone-stimulated calcium transients. High doses of parathyroid hormone could overcome this inhibition. This inhibitory effect appears to be selective, since gallium nitrate did not prevent calcium transients elicited by alpha-thrombin or prostaglandin F1 alpha. Failure of gallium nitrate to prevent calcium transients elicited by these agents, even after the inhibition of parathyroid hormone-induced signal, indicates that the inhibition is not a toxic effect. In conclusion, gallium nitrate has a marked effect on calcium signalling in UMR-106 cells that might be of major importance in modifying the effects of calcemic hormones or local factors on osteoblasts.

Animals↗
PubMed1992

Diurnal rhythms in Ca transfer into bone, Ca release from bone, and bone resorbing activity in serum of rats.

To characterize diurnal rhythms in calcium transfer in and out of bone, rats were adapted to a 12:12 h light-dark illumination program (with light from 0600 to 1800 h). For studies of deposition, rats were injected with 45CaCl2 at 0300, 0700, 1100, 1500, 1900 or 2300 h and killed with chloroform inhalation 60 min later, and radioactivity was determined in tibia and mandibular incisor. Peak deposition occurred at 2400 h, with a nadir at 1200 h. For studies of radionuclide release, rats were prelabeled with 45CaCl2 for 6 days and serum obtained from the tail at 4-h intervals. 45Ca and specific activity were maximal around 1200-1600 h and lowest late in the dark period. To determine the role of humoral factor(s), fetal rat limb bones were cultured in media prepared with sera from light-dark-adapted rats. Activity was maximal in serum collected at 0800 h and minimal at 1600 h. Heat inactivation at 100 degrees C for 5 min eliminated the difference between the peak and nadir. The results suggest that a heat-sensitive humoral factor(s) regulates diurnal rhythms in calcium metabolism.

Animals↗
PubMed1992

Endothelin-1 actions on resorption, collagen and noncollagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures.

The effects of endothelin-1 (ET) on several tissues are mediated by prostaglandins. In this study, we investigated the actions of ET on bone and determined whether they are mediated through prostaglandin-dependent pathways. Bone resorption, collagen, and non-collagen protein synthesis and inositol phosphate (IP) production were studied in neonatal mouse calvaria and fetal rat limb bone cultures. The effects of ET in the calvaria model were examined in the presence or absence of the cyclooxygenase inhibitor indomethacin (INDO). Bone resorption was stimulated by ET in the neonatal mouse calvaria, and this effect was inhibited by INDO. 45Ca release in the fetal rat limb bones was not affected by ET. ET stimulated collagen and noncollagen protein synthesis significantly in the calvaria model in the presence but not in the absence of INDO, suggesting that the anabolic effects of ET were masked by endogenous prostaglandin production. ET increased phosphatidylinositol turnover in both bone organ cultures. Although the addition of INDO reduced IP production slightly in the mouse calvaria, it was still significantly stimulated by ET. Our results demonstrate that ET has marked effects on bone tissue in vitro. Effects on resorption appear to be prostaglandin dependent, whereas the anabolic effects were not prostaglandin mediated. The stimulatory effects of ET on protein synthesis could be mediated through the IP signaling pathway. Since ET stimulates both bone resorption and anabolism, this peptide may have a role in the coupling of bone remodeling.

Animals↗
PubMed1992

Sodium nitroprusside increases cyclic GMP in fetal rat bone cells and inhibits resorption of fetal rat limb bones.

To elucidate the role of cGMP in bone resorption, the nucleotide was measured in bone and bone cells in response to several agents including stimulators of bone resorption. In other experiments, sodium nitroprusside (SNP), which elevates bone cGMP, was tested for effects on resorption. In cells from 20-day fetal rat calvaria, cGMP was 52.4 +/- 8.4 fmol/10(6) cells; cAMP was 5.3 +/- 0.3 pmol/10(6) cells. SNP, 0.1 mM, in the presence of IBMX, increased cGMP 74% with no significant effect on cAMP. Parathyroid hormone (PTH), 0.5 microM, did not significantly affect cGMP, but increased cAMP 711%. Calcitriol did not affect either nucleotide. In bone resorption studies, 0.1 mM SNP inhibited the effects of PTH and calcitriol. Lower concentrations of SNP (0.001, 0.01 mM) had no effects on hormone-stimulated resorption. Unstimulated control bones were not affected by 1 nM-1 mM SNP. The results suggest that elevated cGMP could result in inhibition of bone resorption.

1-Methyl-3-isobutylxanthine↗
PubMed1991

Gallium nitrate inhibits bone resorption and collagen synthesis in neonatal mouse calvariae.

Gallium nitrate (GN) is an agent used in the treatment of hypercalcemia. To more fully characterize the direct actions of GN on bone, we examined its effects on medium calcium, medium beta-glucuronidase (beta-GLU), and collagen synthesis in control and hormone-stimulated neonatal (4-6 days) mouse calvariae in vitro. GN (10 micrograms/ml) inhibited parathyroid hormone-stimulated (PTH; 1 nM) calcium release. A 24 h preincubation with 10 micrograms/ml of GN was required for complete inhibition; partial inhibition was seen with 12 h preincubation; 1, 3, or 6 h was inadequate. A dose-response study showed that with 24 h preincubation, 5, 3, and 1 microgram/ml of GN inhibited 81, 62, and 0% of PTH-induced calcium release. The effects of GN on the release of beta-GLU generally paralleled those on the release of calcium except that 10 micrograms/ml of GN stimulated beta-GLU release. Collagen synthesis was inhibited 50% by 3 micrograms/ml of GN, whereas noncollagen protein synthesis was unaffected. With PTH + GN no further decrease was observed. When GN was withdrawn from the medium after 24 h of preincubation, the inhibitory effect on calcium release and beta-GLU activity, but not on collagen synthesis, persisted through the 72 h of culture. GN also inhibited the resorption elicited by thyroxine (1 microM) and interleukin-1 beta (10 nM) but not by 1,25-dihydroxyvitamin D3 (30 pM). Our results indicate that GN is a powerful inhibitor of bone resorption in neonatal mouse calvariae even at low doses.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1991

Salmon stanniocalcin and bovine parathyroid hormone have dissimilar actions on mammalian bone.

Stanniocalcin (STC), a calcium-regulating glycoprotein hormone isolated from the corpuscles of Stannius of salmon, was tested for effects on bone and calcium metabolism in mammalian species (rats and mice). STC generally failed to alter serum calcium of parathyroidectomized rats at concentrations equimolar with effective concentrations of parathyroid hormone (PTH). STC did not increase cAMP in ROS 17/2.8 or UMR-108 osteosarcoma cells, OK kidney cells, fetal rat limb bones, or neonatal mouse calvariae, and similarly failed to increase urinary cAMP in rats. STC did not consistently stimulate resorption in any of the rodent bone culture systems, although variable resorptive responses were elicited in fetal mouse calvariae. The results indicate that this fish hormone has limited, if any, PTH-like activity on calcium metabolism in mammalian systems.

Animals↗
PubMed1991

Parathyroid hormone (1-34) and Nleu8,18Tyr34-parathyroid hormone, (3-34) amide increase diacylglycerol in neonatal mouse calvaria.

Previously, we and others have presented evidence that a calcium second messenger system is involved in the action of parathyroid hormone (PTH) on bone. In the present report, the effects of PTH(1-34) and PTH(3-34)amide treatment on diacylglycerol (DG) in neonatal mouse calvaria are described. PTH(1-34) produced a rapid (within 5 minutes) increase in calvarial incorporation of 3H-arachidonic acid into DG. The effect was maximal at 0.1 nMPTH(1-34), the lowest concentration tested. The 3-34 amide analogue of PTH increased DG to the same extent as PTH(1-34). The effect was maximal at 10 nM PTH(3-34)amide, the lowest concentration tested. These concentrations were lower than those required to elicit maximal effects on bone resorption. In contrast to effects on cyclic AMP, where the 3-34 amide inhibited the increase elicited by PTH, combined treatment of calvaria with PTH(1-34) and PTH(3-34)amide did not inhibit effects on resorption or diacylglycerol.

Animals↗
PubMed1991

Evidence for direct non-genomic effects of triiodothyronine on bone rudiments in rats: stimulation of the inositol phosphate second messenger system.

Thyroid hormones increase cytosolic free calcium by binding to plasma membrane receptors in several tissues. This calcium increase appears to initiate extranuclear effects in these tissues. Increases in cytosolic calcium are often a consequence of stimulation of inositol phosphate second messenger pathway. Several calcemic hormones act via this signal transduction route. Therefore we investigated the effects of the metabolically active T3 and the inactive analogues 3,5-diiodotyrosine and rT3 on the inositol phosphate pathway in fetal rat limb bone cultures prelabeled with [3H]myoinositol. Labelled inositol and inositol phosphates were separated by HPLC. There was a significant increase in the radioactivity in inositol bis- and trisphosphates after 1 min of exposure to 10(-7) mol/l T3. Stimulation was also observed at 10(-6) mol/l T3, but not at 10(-5) mol/l. Time course studies demonstrated a rapid effect of T3 on inositol phosphates within 30 seconds that lasted through 5 min. After 20 min incubation with T3, no increase was observed in inositol mono- and bisphosphates, and a decrease was seen in inositol trisphosphate. Pretreatment with indomethacin prevented these effects of T3. 3,5-diiodotyrosine and rT3 did not affect inositol phosphate metabolism. These results suggest the existence of plasma membrane-associated receptors for T3 in bone, in addition to the nuclear receptors demonstrated previously. The role of these receptors in the effects of thyroid hormones on bone remains to be established.

Animals↗
PubMed1991

Alpha-difluoromethylornithine inhibits bone resorption in vitro without decreasing beta-glucuronidase release.

Our previous studies suggested that the ornithine decarboxylase inhibitor alpha-difluoromethylornithine (DFMO) inhibits bone resorption by mechanisms that are independent of polyamine depletion. To determine whether DFMO prevents calcitriol-stimulated bone resorption by acting at a step before or after osteoclast activation, we compared the effects of DFMO on release of calcium and beta-glucuronidase from cultured neonatal mouse calvaria. DFMO, at concentrations of 7.5-20 mM, inhibited release of calcium from calcitriol-stimulated calvaria but failed to inhibit the calcitriol-stimulated increase in beta-glucuronidase secretion. In contrast, ornithine, putrescine, spermidine, and spermine, at concentrations with effects on resorption comparable to those of DFMO, inhibited the effects of calcitriol on both calcium and beta-glucuronidase release. NaF (0.2 mM), like DFMO, inhibited calcitriol-stimulated calcium release without affecting medium beta-glucuronidase activity, whereas elevated phosphate (3 mM) inhibited both activities. The results suggest that DFMO, over the concentration range studied, inhibits calcium release by making the matrix resistant to resorption rather than by acting at a cellular locus.

Animals↗
PubMed1990

24- and 26-homo-1,25-dihydroxyvitamin D3 analogs: potencies on in vitro bone resorption differ from those reported for cell differentiation.

It has been proposed that the stimulatory effects of 1,25-dihydroxyvitamin D on bone resorption may be mediated through actions on differentiation of marrow cells into monocytic osteoclast precursors. In human promyelocytic leukemia cells (HL-60), 24- and 26-homo-1,25-dihydroxyvitamin D3 and their delta 22 analogs and 24,24-dihomo-1,25-dihydroxyvitamin D3 are 10-fold more potent than 1,25-dihydroxyvitamin D3, and delta 22-24,24,24-trihomo-1,25-dihydroxyvitamin D3 is equipotent with 1,25-dihydroxyvitamin D3 in inducing differentiation into the monocytic phenotype. The effect of these 1,25-dihydroxyvitamin D3 analogous on resorption of fetal rat limb bones in vitro was determined in the present study. 1,25-Dihydroxyvitamin D3 was equipotent with 24-homo-1,25-dihydroxyvitamin D3, delta 22-24-homo-1,25-dihydroxyvitamin D3, 26-homo-1,25-dihydroxyvitamin D3, and delta 22-26-homo-1,25-dihydroxyvitamin D3 for in vitro bone resorption, whereas 24,24-dihomo-1,25-dihydroxyvitamin D3 and delta 22-24,24,24-trihomo-1,25-dihydroxyvitamin D3 were inactive. The failure of these analogs to show a higher bone-resorbing activity than 1,25-dihydroxyvitamin D3 were inactive. The failure of these analogs to show a higher bone-resorbing activity than 1,25-dihydroxyvitamin D3 provides evidence to suggest that the mechanism of 1,25-dihydroxyvitamin D3-induced bone resorption may not involve stimulation of monocytic cell differentiation.

Animals↗
PubMed1990

Second messengers in thrombin-stimulated bone resorption.

Characterized human thrombins and two commercial bovine thrombin preparations were examined for their effects on bone resorption and on the cyclic AMP and phosphoinositide second messenger systems in bone. Human alpha- and gamma-thrombins, as well as both bovine thrombin preparations, stimulated bone resorption in vitro, whereas catalytically inactivated human diisopropylfluorophosphate (DIP)-alpha-thrombin did not significantly stimulate resorption. Human alpha-thrombin and a commercial bovine thrombin preparation increased cyclic AMP production in fetal rat limb bones, but another bovine commercial thrombin preparation and gamma-thrombin did not. Except for DIP-alpha-thrombin, all thrombins increased production of inositol phosphates in fetal rat limb bones at concentrations that stimulated resorption. In time course studies, bovine thrombin increased label in inositol trisphosphate at 30 s, with decreasing effects at later times. Inositol monophosphate increased progressively over 30 min. Our results are consistent with thrombin-stimulated bone resorption being mediated at least partially through the inositol phosphate pathway.

Animals↗
PubMed1990

Vitamin D and bone.

Recent studies of the effects of vitamin D on bone include characterization of the receptors for 1,25-(OH)2D3 in bone and bone derived cells. The receptors show similar affinities in the different tissues. The receptor concentration is affected by the stage of the cell cycle. Glucocorticoid treatment affects the number of receptor sites. The most extensively studied effects of 1,25-(OH)2D3 on macromolecular synthesis in bone have been on collagen, where both anabolic and antianabolic effects are found. Differences in the response may reflect the state of differentiation of the cells. Significant effects are seen on osteocalcin synthesis, although the role of this protein in vitamin D action on bone is still unclear. 1,25-(OH)2D3 influences the activity of alkaline phosphatase and 25-OH-D3 24-hydroxylase in bone. Receptors for growth factors, and production of cytokines may be influenced by 1,25-(OH)2D3 treatment. Although some of these findings would be consistent with direct anabolic effects of vitamin D or its metabolites on bone, such a process has yet to be integrated into the complete picture of vitamin D action at physiological and pharmacological levels in vivo. Recent studies are consistent with earlier results that indicate that hypercalcemic effects of 1,25-(OH)2D3 are mediated by a direct effect on bone. Studies with analogs of 1,25-(OH)2D3 suggest that the stimulation of bone resorption can be dissociated from effects on differentiation of cells of the monocyte lineage.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1989

Inhibition of bone resorption by alpha-difluoromethylornithine may not be mediated by polyamine depletion.

We have examined the effect of alpha-difluoromethylornithine (DFMO) on bone polyamine content and parathyroid hormone (PTH)- and calcitriol-stimulated bone resorption in cultures of neonatal mouse calvaria. Polyamine content in bone homogenates was determined by reverse-phase paired-ion HPLC. Treatment with 5 mM DFMO for 48 h reduced putrescine from 0.4 nmol/bone to nondetectable levels, slightly decreased spermidine, and did not affect spermine. Bone resorption elicited by 48 h of treatment with PTH or calcitriol was inhibited by concentrations of DFMO greater than or equal to 5 mM added 48 h prior to hormone. This observation supported the concept that polyamines may play a role in bone resorption. However, other observations cast uncertainty on this conclusion. Measurement of calvarial polyamine content at 2 h intervals revealed no increase in endogenous polyamines for up to 10.5 h after calcitriol addition. Although addition of putrescine restored bone polyamine content, exogenous polyamines failed to reverse the inhibitory effects of DFMO on calcitriol-stimulated resorption. These results suggest that a mechanism other than depletion of polyamines could be contributing to the inhibitory effect of DFMO on resorption.

Animals↗
PubMed1989

Cyclosporines: correlation of immunosuppressive activity and inhibition of bone resorption.

Cyclosporine A (CsA) is a potent immunosuppressive agent that inhibits stimulated bone resorption in vitro. To study the mechanism of this effect, we have compared CsA with several cyclosporine analogs that vary in immunosuppressive potency. CsA as well as another potent immunosuppressive analog, CsG, inhibited parathyroid hormone (PTH) and interleukin-1 (IL-1)-stimulated resorption of fetal rat limb bones. The nonimmuno-suppressive analogs CsH and CsF did not inhibit PTH or IL-1-stimulated bone resorption. Likewise, the weakly immunosuppressive analog CsD did not significantly inhibit PTH-stimulated bone resorption. Although other mechanisms cannot be excluded, our data are consistent with the concept that bone resorption may involve an immune cell-derived mediator.

Animals↗